相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cystic Fibrosis Transmembrane Conductance Regulator Activation by Roflumilast Contributes to Therapeutic Benefit in Chronic Bronchitis
James A. Lambert et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review
Charlotte Suppli Ulrik
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
Cigarette smoke and CFTR: implications in the pathogenesis of COPD
Andras Rab et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Identification of the SPLUNC1 ENaC- inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures
Carey A. Hobbs et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
The role of macrophages in obstructive airways disease: Chronic obstructive pulmonary disease and asthma
Konstantinos Pappas et al.
CYTOKINE (2013)
Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro
J. Milara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration
Lucy A. Clunes et al.
FASEB JOURNAL (2012)
A Pharmacologic Approach to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Smoking Related Lung Disease
Peter A. Sloane et al.
PLOS ONE (2012)
Multiple Facets of cAMP Signalling and Physiological Impact: cAMP Compartmentalization in the Lung
Anouk Oldenburger et al.
PHARMACEUTICALS (2012)
Pharmacology and Therapeutics of Bronchodilators
Mario Cazzola et al.
PHARMACOLOGICAL REVIEWS (2012)
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
E. D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Pharmacokinetic evaluation of roflumilast
Gezim Lahu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Defective adenosine-stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling
Michael J. Watson et al.
FASEB JOURNAL (2011)
The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Armin Hatzelmann et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Miles D. Houslay
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
Donald P. Tashkin et al.
RESPIRATORY RESEARCH (2010)
The Pathology of Chronic Obstructive Pulmonary Disease
James C. Hogg et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Samiya Razvi et al.
CHEST (2009)
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
Leonardo M. Fabbri et al.
LANCET (2009)
Adenosine receptors in COPD and asymptomatic smokers: effects of smoking cessation
Mieke Versluis et al.
VIRCHOWS ARCHIV (2009)
Effect of β2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells:: a role for protein kinase A
Manminder Kaur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Cyclic AMP - Master regulator of innate immune cell function
Carlos H. Serezani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposure
Lucy A. Clunes et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2008)
β2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics
Jonathan D. Violin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of respiratory disease
Victoria Boswell-Smith et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers
Andre M. Cantin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia
R Tarran et al.
JOURNAL OF GENERAL PHYSIOLOGY (2006)
Mucus clearance and lung function in cystic fibrosis with hypertonic saline
SH Donaldson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation
M Johnson
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors
SS Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium
AP Barnes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nucleotide release provides a mechanism for airway surface liquid homeostasis
ER Lazarowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mediators of chronic obstructive pulmonary disease
PJ Barnes
PHARMACOLOGICAL REVIEWS (2004)
Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease
AJ Hirsh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
A macromolecular complex of β2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA
AP Naren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The volatile fraction of cigarette smoke induces alterations in the human gingival fibroblast cytoskeleton
P Poggi et al.
JOURNAL OF PERIODONTAL RESEARCH (2002)
The CF salt controversy: In vivo observations and therapeutic approaches
R Tarran et al.
MOLECULAR CELL (2001)
Regulation of G protein-coupled receptor-adenylyl cyclase responsiveness in human airway smooth muscle by exogenous and autocrine adenosine
SJ Mundell et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
分享论文
